Companion Diagnostics Market Size to Grow at 9% CAGR, Reaching US$ 9.30 Billion by 2028, Fueled by Rising Demand for Personalized Medicine and Increasing Cancer Incidence - Latest TMR Report

The global companion diagnostics market(https://www.transparencymarketresearch.com/companion-diagnostics-market.html) size stood at US$ 5.24 Bn in 2020 and is anticipated to surpass US$ 9.30 Bn by 2028. The industry is projected to expand at a CAGR of 9% during the forecast period from 2021 to 2028. Rising prevalence of chronic diseases such as cancer, HIV, and thalassemia, combined with advancements in personalized medicine, are key drivers accelerating market growth.

Companion diagnostics are biological tests that help determine the efficacy and safety of specific drug therapies for particular patients. They are instrumental in tailoring personalized treatments in oncology and other chronic illnesses, thereby improving patient outcomes and minimizing healthcare costs.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387

Rise in Cancer Cases and Technological Advances to Drive Market Growth

According to Transparency Market Research, increasing incidence of breast, lung, and colorectal cancers is spurring demand for precision diagnostics. Companion diagnostics are crucial for identifying which patients are likely to benefit from specific drugs, thereby enhancing therapeutic efficiency and reducing adverse effects. The breast cancer segment held the largest market share in 2020 and is expected to maintain dominance throughout the forecast period.

Technological innovations, such as biomarker discovery and high-throughput genomic platforms, are also propelling the companion diagnostics industry forward. In 2020 alone, over 44 companion diagnostic assays were approved by the U.S. FDA, reinforcing the positive regulatory environment for market expansion.

Key Findings of the Market Report

Market Value in 2020: US$ 5.24 Bn

Expected Market Value by 2028: US$ 9.30 Bn

CAGR: 9% (2021-2028)

Primary Growth Drivers:
Rising cancer incidence globally
Demand for personalized medicine
Technological advancements and regulatory support

Key Restraints:
Lengthy approval timelines
Lack of reimbursement in certain regions

COVID-19 Impact: Market Recovery Underway

The COVID-19 pandemic disrupted the global healthcare ecosystem, delaying elective procedures and clinical trials in oncology. These delays significantly impacted companion diagnostics development and deployment. However, market players have undertaken collaborative strategies and resumed clinical trials, leading to a strong post-pandemic recovery trajectory.

Growing Focus on Personalized Medicine and Early Diagnosis

Healthcare providers and pharmaceutical companies are increasingly investing in personalized treatment options. Companion diagnostics reduce trial-and-error approaches in pharmacotherapy and enhance drug development success rates. This shift is supported by the growing need for precision in treating chronic and life-threatening diseases.

The integration of companion diagnostics with next-generation sequencing (NGS) and artificial intelligence is likely to open new growth avenues, especially in emerging markets with improving healthcare infrastructure.

Regional Landscape: North America Leads, Asia Pacific Shows High Growth Potential

North America accounted for the largest share of the global market in 2020, driven by robust healthcare infrastructure, high healthcare expenditure, and the strong presence of market players. In the United States alone, over 1.8 million new cancer cases were diagnosed in 2020, underscoring the urgent need for effective diagnostic tools.

Asia Pacific is anticipated to register the highest growth rate during the forecast period. Rapid urbanization, increased government investment in healthcare, and rising awareness about early cancer detection are expected to support regional market expansion. Countries such as China, India, and Japan are emerging as hotspots for clinical research and diagnostics innovation.

Competitive Landscape

Prominent players operating in the global companion diagnostics market include:

Labcorp Drug Development
Agilent Technologies
Myriad Genetic Laboratories, Inc.
Qiagen
Roche Molecular Systems, Inc.
Dako, Inc.
Abbott
Foundation Medicine, Inc.
Ventana Medical Systems, Inc.
Illumina, Inc.
bioMérieux, Inc.
GE Healthcare
Agendia N.V.
Exact Sciences Corp.
Genomic Health

These companies are focusing on strategic collaborations, regulatory approvals, and new product development to gain a competitive edge.

Market Segmentation:

By Indication

Breast Cancer
Lung Cancer
Colorectal Cancer
Gastric Cancer
Melanoma
Others (HIV, Thalassemia)

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Key Trends and Opportunities

Growing adoption of NGS-based companion diagnostics
Expansion of pharmaceutical partnerships for co-development
Increasing healthcare investment in emerging economies
Rising awareness and education around cancer screening

Buy this Premium Research Report:

https://www.transparencymarketresearch.com/checkout.php?rep_id=387<ype=S

Explore Latest Research Reports by Transparency Market Research:

Biological Safety Cabinet Market- https://www.transparencymarketresearch.com/biological-safety-cabinet-market.html

U.S., Europe, and Japan AI in Endoscopy Market- https://www.transparencymarketresearch.com/us-europe-and-japan-ai-in-endoscopy-market.html

Fetal Doppler Market- https://www.transparencymarketresearch.com/fetal-doppler-market.html

mRNA Vaccine Market- https://www.transparencymarketresearch.com/mrna-vaccine-market.html

Acrylic Teeth Market- https://www.transparencymarketresearch.com/acrylic-teeth-market.html

Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.